For the quarter ending 2025-09-30, GMRE had $614K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | -5,058 | 4,322 |
| Depreciation expense | 11,213 | 21,614 |
| Amortization of acquired lease intangible assets | 3,536 | 7,046 |
| Amortization of above market leases, net | 113 | 392 |
| Amortization of debt issuance costs and other | 554 | 1,118 |
| Stock-based compensation expense | 1,207 | 1,879 |
| Capitalized preacquisition and other costs charged to expense | 16 | 42 |
| (gain) loss on sale of investment properties | 294 | 1,565 |
| Impairment of investment property | 6,281 | - |
| Equity loss from unconsolidated joint venture | 32 | 91 |
| Other | -24 | -70 |
| Tenant receivables | 120 | 402 |
| Deferred assets | 558 | 536 |
| Other assets and liabilities | -229 | 2,059 |
| Accounts payable and accrued expenses | 286 | 2,316 |
| Security deposits | 105 | 83 |
| Net cash provided by operating activities | 17,566 | 34,411 |
| Purchase of land, buildings, and other tangible and intangible assets and liabilities | 0 | 70,468 |
| Net proceeds from sale of investment property | 3,584 | 9,111 |
| Distribution of capital from unconsolidated joint venture | 39 | 58 |
| Escrow deposits for purchase of properties | 0 | -290 |
| Advances made to related parties | 94 | -191 |
| Capital expenditures on existing real estate investments | 3,284 | 4,576 |
| Leasing commissions | 1,136 | 673 |
| Net cash used in investing activities | -703 | -66,449 |
| Repayment of notes payable | 13,004 | 264 |
| Proceeds from credit facility | 20,900 | 94,500 |
| Repayment of credit facility | 11,800 | 28,500 |
| Dividends paid to common stockholders, and op unit and ltip unit holders | 10,890 | 30,503 |
| Dividends paid to preferred stockholders | 1,455 | 2,911 |
| Net cash provided by financing activities | -16,249 | 32,322 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | 614 | 284 |
| Cash and cash equivalents at beginning of period | 8,942 | - |
| Cash and cash equivalents at end of period | 9,840 | - |
Global Medical REIT Inc. (GMRE)
Global Medical REIT Inc. (GMRE)